Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction

Abstract

Tofacitinib modulates the innate and adaptive immune responses, ameliorates murine lupus, and improves vascular function. These results indicate that JAK inhibitors have the potential to be beneficial in SLE and its associated vascular damage.